| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/23/2006 | EP1290939B1 Caspase 1 gene transfer animal |
| 08/23/2006 | EP1278716B1 Trans-n-¬4-(4-hydroxyphenyl)cyclohexyl|-3-phenylpropionamide as subtype selective nmda receptor antagonist |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1189637B1 Compositions for improving bioavailability of orally administered drugs |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | EP0833636B1 Method for inhibiting neoplastic disease in mammals |
| 08/23/2006 | CN1822880A Parasiticidal composition |
| 08/23/2006 | CN1822828A Substituted 1, 4-di-piperidin-4-yl-piperazine derivative combined with an opioid analgesic and their use for the treatment of pain and side-effects associated with opioid-based treatments |
| 08/23/2006 | CN1822825A Treatment of anxiety disorders |
| 08/23/2006 | CN1822820A Treatment and prevention of cardiovascular events |
| 08/23/2006 | CN1822817A Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 08/23/2006 | CN1822765A Delivery of compounds with rehydrated blood cells |
| 08/23/2006 | CN1820794A Intelligent cerebrospinal fluid displacement instrument |
| 08/23/2006 | CN1820756A Methods for treating stress disorders using glucocorticoid receptor-specific antagonists |
| 08/23/2006 | CN1820734A Treatment with anti-erbb2 antibodies |
| 08/23/2006 | CN1271070C Derivatives of triazolyl-imidazopyridine and of the triazolylpurines useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 08/23/2006 | CN1270776C Ulcer quieting medicine its preparation and use |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/23/2006 | CN1270719C Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 08/23/2006 | CN1270713C Synergistic pharmaceutical combination for prevention or treatment of diabetes |
| 08/23/2006 | CN1270707C Ophthalmic solution |
| 08/22/2006 | US7094895 Inotropic agents such as (S)-N-tert-butyloxycarbonyl-N-methyl-tyrosyl)-4-(4-nitrophenyl)-piperazine, used for preventing and/or prophylaxis of diseases associated with adenosine 5'-triphosphate |
| 08/22/2006 | US7094889 AGE-1 polypeptides and related molecules and methods |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094797 Organ fibrosis inhibitor |
| 08/22/2006 | US7094788 A tropane ester derivative for treating asthma, chronic obstractive pulmonary disease, vagally induced sinus bradycardia, heart rhythm disorders, spasms in the gastrointestinal or urinary tracts, and menstrual pain |
| 08/22/2006 | US7094786 Method of treating nausea, vomiting, retching or any combination thereof |
| 08/22/2006 | US7094784 High affinity ligands for nociceptin receptor ORL-1 |
| 08/22/2006 | US7094750 Toxin for use in treating cancer; antitumor agents |
| 08/22/2006 | US7094556 Diagnosis and treatment of malignant neoplasms |
| 08/22/2006 | US7094549 mass spectroscopy; medical diagnosis/prognosis; kits |
| 08/22/2006 | US7094547 Sperm specific proteins |
| 08/22/2006 | US7094546 screening gene expression inhibition via incubating mrna, determining expression in presence of test compound, then comparing levels; gene knockout |
| 08/22/2006 | US7094431 Method of healing skin wounds in mammals and a composition therefor |
| 08/22/2006 | US7094424 Cationic lipid compositions targeting angiogenic endothelial cells |
| 08/22/2006 | US7094413 Combined therapy for treatment of HIV infection |
| 08/22/2006 | US7094397 Methods and reagents for the treatment of multiple sclerosis |
| 08/22/2006 | US7094392 Heating antihistamine drug vaporize; cooling to form a condensation aerosol; kit for dispensing thin coating |
| 08/22/2006 | CA2214979C Improvements in or relating to organic compositions |
| 08/17/2006 | WO2006086643A1 Method and composition for treating mammalian diseases and injuries caused by the over-expression of peroxynitrite |
| 08/17/2006 | WO2006086500A2 Compositions and methods for treating vascular, autoimmune and inflammatory diseases |
| 08/17/2006 | WO2006086445A2 Combination therapy |
| 08/17/2006 | WO2006085988A1 Methods for treating parkinson’s disease |
| 08/17/2006 | WO2006085692A1 Crystal of 4(3h)-quinazolinone derivative |
| 08/17/2006 | WO2006085689A1 Anticancer agent to be combined with telomelysin |
| 08/17/2006 | WO2006085688A1 Psychogenic pain therapeutic agent |
| 08/17/2006 | WO2006085686A1 Remedy for neurogenic pain |
| 08/17/2006 | WO2006085648A1 Novel narcolepsy-related gene |
| 08/17/2006 | WO2006085521A1 Medicinal composition for transdermal absorption containing opipid receptor antagonist, method of producing the same and method of promoting the transdermal absorption of the antagonist |
| 08/17/2006 | WO2006085510A1 Remedy for irritable bowel syndrome |
| 08/17/2006 | WO2006085219A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy |
| 08/17/2006 | WO2006084757A2 Combination of ca/mg salt of valsartan with an antidiabetic agent |
| 08/17/2006 | WO2006084694A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition |
| 08/17/2006 | WO2006084337A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006084327A1 A molecule and chimeric molecules thereof |
| 08/17/2006 | WO2006052373A3 Method for treating hiv infection through co-administration of tipranavir and etravirine |
| 08/17/2006 | WO2006025767A3 Perorally administrable antimicrobial composition |
| 08/17/2006 | WO2005123068A3 Methods of dealying alzheimer’s disease progression using a beta-amyloid precursor protein inhibitor and a hmg coa reductase inhibitor |
| 08/17/2006 | WO2005117895A3 Compositions comprising meloxicam |
| 08/17/2006 | WO2005106039A8 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 08/17/2006 | WO2005102389A3 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| 08/17/2006 | WO2005058237A3 Treatment of aids |
| 08/17/2006 | WO2004093816A3 Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent |
| 08/17/2006 | WO2003088904A3 Screening and therapeutic methods for treating circadian rhythm disorders |
| 08/17/2006 | WO2003066071A8 Formulations comprising psychotropic drugs and selenium |
| 08/17/2006 | WO2003053346A3 Systems and methods for treating patients with processed lipoaspirate cells |
| 08/17/2006 | US20060183805 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
| 08/17/2006 | US20060183798 Method for preventing and/or treating peripheral neuropathies induced by the administration of an anticancer agent |
| 08/17/2006 | US20060183793 Method of treating hematologic tumors and cancers |
| 08/17/2006 | US20060183789 Methods for preventing and treating obesity in patients with mc4 receptor mutations |
| 08/17/2006 | US20060183784 Human growth hormone antagonists |
| 08/17/2006 | US20060183778 Osteogenesis-promotion enhancer and method of screening the same |
| 08/17/2006 | US20060183774 Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
| 08/17/2006 | US20060183765 Methods of treating cancer using an FPT inhibitor and antineoplastic agents |
| 08/17/2006 | US20060183757 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 08/17/2006 | US20060183755 Tyrosine kinase inhibitors |
| 08/17/2006 | US20060183741 Treatment of associated conditions and disorders such as gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 08/17/2006 | US20060183737 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists |
| 08/17/2006 | US20060183728 Combination chemotherapy compositions and methods |
| 08/17/2006 | US20060183713 Compositions of low molecular weight heparin produced with modified heparinase III |
| 08/17/2006 | US20060183708 Topical Delivery of Trace Metals for Enzyme Modulation |
| 08/17/2006 | US20060183695 Methods of increasing endogenous erythropoietin (EPO) |
| 08/17/2006 | US20060183687 Novel therapeutic molecules |
| 08/17/2006 | US20060183674 Compositions and methods for treating diabetes |
| 08/17/2006 | US20060183664 Pharmaceutical composition for delayed hypersensitivity |
| 08/17/2006 | US20060183192 Modulation of sodium channels in dorsal root ganglia |
| 08/17/2006 | US20060183186 Gene expression profiles in stomach cancer |
| 08/17/2006 | US20060183160 Novel beta-secretase and modulation of beta-secretase activity |
| 08/17/2006 | US20060183105 Human brain-derived tissue-specific potassium channel |
| 08/17/2006 | US20060182813 Colloidal silver composition having microbial properties |
| 08/17/2006 | US20060182802 Rapidly disintegrable solid preparation |
| 08/17/2006 | US20060182800 Novel pharmaceutical compositions for antihistaminic-decongestant combination and method of making such compositions |
| 08/17/2006 | US20060182795 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders |
| 08/17/2006 | US20060182755 Novel composition and methods for the treatment of psoriasis |
| 08/17/2006 | US20060182734 Contacting polysaccharide with disaccharide repeat unit of uronic acid [ alpha -L-iduronic acid or beta -D-glucuronic acid ] linked 1, 4 to alpha -D-hexosamine with mutant heparinase III; sequencing mucopolysaccharides; antitumor, anticarcinogenic and antimetastasis agents; angiogenesis inhibitors |
| 08/17/2006 | US20060182718 Methods and compositions comprising DNA damaging agents and p53 |
| 08/17/2006 | US20060182701 Tissue culture media used as a component of cosmetics |